Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Age-related macular degeneration

- PMLiVE

Astellas signs $962m rare eye disease deal with 4D Molecular Therapeutics

The company will gain the rights to use 4DMT’s gene therapy vector for at least one target

- PMLiVE

Astellas to acquire Iveric Bio for approximately $5.9bn

The deal includes the US drugmaker’s lead candidate for geographic atrophy

- PMLiVE

Positive results for Astellas’ zolbetuximab in gastric cancer published in The Lancet

Over one million new cases of gastric cancer were diagnosed globally in 2020

- PMLiVE

Biogen takes on Lucentis, Eylea biosimilars from Samsung joint venture

Will pay $100m upfont and pledges $210m in milestone payments

- PMLiVE

The power of pharma businesses to drive social change

The importance of CSR programmes

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links